AstraZeneca announces changes to Senior Executive Team
AstraZeneca unveiled changes to its executive leadership team...
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
List view / Grid view
AstraZeneca unveiled changes to its executive leadership team...
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
Top-line results of OSKIRA-4...
13 December 2012 | By AstraZeneca
Top-line results of OSKIRA-4...
AstraZeneca announced positive top-line results from two Phase III trials...
12 November 2012 | By AstraZeneca
AstraZeneca announced positive top-line results from two Phase III trials...
Funding for 15 research projects...
31 October 2012 | By AstraZeneca
Funding for 15 research projects...
European Commission approves ZINFORO™...
28 August 2012 | By AstraZeneca
European Commission approves ZINFORO™...
Zinforo receives positive CHMP opinion...
22 June 2012 | By AstraZeneca
Zinforo receives positive CHMP opinion...
AstraZeneca has announced new restructuring initiatives designed to improve productivity…
2 February 2012 | By AstraZeneca
AstraZeneca has announced new restructuring initiatives designed to improve productivity and strengthen the company’s capabilities...
AstraZeneca has entered into a three-year collaboration agreement with IMS…
11 January 2012 | By AstraZeneca
AstraZeneca has entered into a three-year collaboration agreement with IMS Health...
One of the world’s most renowned “drug hunters” has been…
11 August 2011 | By University of Brighton
One of the world’s most renowned “drug hunters” has been awarded an honorary Doctor of Science from the University of Brighton...